A Non-Interventional Multi-country Study to Evaluate the Real World Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 24 Jan 2018 Status changed from active, no longer recruiting to completed.
- 10 Oct 2017 Planned End Date changed from 1 Oct 2016 to 30 Nov 2017.
- 10 Oct 2017 Status changed from not yet recruiting to active, no longer recruiting.